Non-Hodgkin Lymphoma

December 21, 2016

Opdivo May Help Those With Two Types of Non-Hodgkin’s Lymphoma

News

The FDA-approved Hodgkin’s-lymphoma treatment Opdivo (nivolumab) may also be effective against primary central nervous system lymphoma (PCNSL) or primary testicular lymphoma (PTL), case studies suggest. Researchers presented the results at ... Read more

October 10, 2016October 10, 2016

DNA Pattern Offers Clues into Origin of Aggressive Lymphoma, and Ways of Treating It

News

Therapies that interfere with the DNA methylation pattern may be a promising treatment approach for patients with anaplastic large cell lymphoma (ALCL), a new study suggests, demonstrating that ALCL cells have DNA ... Read more

September 29, 2016

Interim Analysis Shows Promise for KTE-C19 in Treating Aggressive Non-Hodgkin Lymphomas

News

Kite Pharma recently reported positive data from an interim analysis of ZUMA-1, a clinical trial assessing the safety and efficacy of KTE-C19 in patients with chemorefractory diffuse large B-cell lymphoma (DLBCL). KTE-C19 is an ... Read more

September 12, 2016September 12, 2016

T-Cell and Chemo Combination Seen to Induce Remission in Advanced NHL Patients

News

Results from an early clinical study in advanced non-Hodgkin’s lymphoma (NHL) showed that 50 percent patients went into complete remission after receiving a combination of chemotherapy and JCAR014, a product based on Chimeric ... Read more

July 22, 2016July 22, 2016

Who Gets Chemotherapy for HIV-associated Lymphoma? Depends on Socioeconomic Factors, Study Says

News

Chemotherapy has been shown to prolong the survival of patients with HIV-associated lymphomas, but new data has revealed that not all patients are equally likely to receive chemotherapy. According to ... Read more

June 22, 2016June 22, 2016

Epizyme Presents Positive Clinical Data on Tazemetostat in Relapsed or Refractory Non-Hodgkin’s Lymphoma

News

Epizyme announced new and positive data from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of orally administered tazemetostat in relapsed or refractory patients with non-Hodgkin’s lymphoma. The ... Read more

June 21, 2016June 21, 2016

HIV-Related Lymphoma: Autologous Hematopoietic Cell Transplant Recommended as Standard of Care

News

Patients with HIV-associated lymphoma who receive autologous hematopoietic cell transplantation (AHCT) have similar survival rates and complication rates than non-HIV lymphoma patients, suggesting that AHCT should be added as standard of ... Read more

June 20, 2016June 20, 2016

Phase 2 Study of Candidate for Refractory Indolent Non-Hodgkin Lymphoma Patients So-So

News

Infinity Pharmaceuticals recently announced that its Phase 2 clinical trial Dynamo evaluating the efficacy and safety of duvelisib in patients with refractory indolent non-Hodgkin lymphoma (iNHL) met its primary endpoint but ... Read more

June 9, 2016June 17, 2016

Brian’s Story: High-Grade Non-Hodgkin Lymphoma – Mantle Cell Lymphoma

“Brian was diagnosed with a type of high-grade non-Hodgkin lymphoma called mantle cell lymphoma. Watch Brian’s video to discover more about his experience with lymphoma, from diagnosis, through treatment and ... Read more